Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT05079243 |
Other study ID # |
H-21004160 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 4, 2021 |
Est. completion date |
June 1, 2023 |
Study information
Verified date |
November 2022 |
Source |
Stemform |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Investigate the effect of dermal/subcutaneous injection of ASC enriched fat transplant in a
protective natural scaffold, designed to sustain the ASC viability after dermal/subcutaneous
injection.
Description:
The study investigates the effect of different concentrations of autologous ex-vivo expanded
adipose-derived stromal cells (ASCs), fat and a natural scaffold for skin rejuvenation and
augmentation. The aim is to better the volume of fat grafts for cosmetic and reconstructive
purposes. Fat is a near ideal filler, as it is biocompatible. However the retention rate of
fat grafts often result in poor outcomes and it is unpredictable. The investigators have set
up an experimental study in which participants with excess abdominal skin is recruited. They
will have injections with 11 different solutions of fat, ACSs, scaffold and dermal CO2 laser
in the abdominal skin. After 3 months biopsies will be taken and after 6 months all of the
treated area will be removed by an cosmetic abdominoplasty.